Another Delay To UK’s VPAG Deadline As Global Uncertainty Continues

 
• By Eliza Slawther
  
Pharma firms in the UK have more time to consider whether to opt-out of the UK voluntary pricing scheme (Shutterstock)

More from Generics

More from Products